Search
AVTECH Scientific has revealed that, in collaboration with Guangzhou Guangjin Life & Health Industry Investment Fund Partnership and Hunan Xiangjiang New Area Guidance No.1 Venture Capital Partnership, it has collectively injected 30 million yuan into Luying Technology. Among the investors, AVTECH Scientific contributed 10 million yuan. Post-capital infusion, AVTECH Scientific will possess a 9.0744% equity share in Luying Technology. Luying Technology, a fledgling enterprise, presently registers zero sales revenue and profits. Its flagship product, the high-end medical imaging SPECT/CT, remains in the developmental phase. Consequently, there are uncertainties surrounding the successful research and development of this product in the future, as well as the timely completion of medical device certification applications.
-
C114 Communication Network -
Communication Home
